1 Min Read
Oct 24 (Reuters) - U.S. Food and Drug Administration:
* U.S. FDA - SINCE SEPT 14 COMMUNICATION, HAS CLASSIFIED ALCON'S MARKET WITHDRAWAL OF CYPASS MICRO-STENT AS A CLASS I RECALL Source text: [bit.ly/2AqFjqh] Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.